Search Within

Patrick Martin

Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Cell Biology Program Faculty (2)
  2. Sloan Kettering Institute Faculty (2)
People
  1. Ethan Dmitrovsky (7)
  2. Kathryn Nason-Burchenal (7)
  3. Janet Allopenna (6)
  4. Malcolm Moore (2)
  5. Joan Albanell (1)
Years
  1. 2007 (1)
  2. 1998 (2)
  3. 1997 (1)
  4. 1996 (2)
  5. 1995 (2)
Publications
  1. Blood (3)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  3. Differentiation (1)
  4. Oncogene (1)
  5. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Society of Hematology (3)
  2. American Association for Cancer Research (2)
  3. International Society of Differentiation (1)
  4. National Academy of Sciences (1)
  5. Nature Publishing Group (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 3 randomized, historically-controlled clinical trial investigating the use of defibrotide in the treatment of severe veno occlusive disease Post-SCT: A novel approach to the validation of a promising new drug for the treatment of a life threatening disease
    Meeting Abstract

    Richardson, P.; Keman, N.; Tomblyn, M.; Martin, P.; Arai, S.; Brochstein, J.; Guinan, E.; Steinbach, G.; Nemecek, E.; D'Agostino, R.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Targeting the PML/RARα translocation product triggers apoptosis in promyelocytic leukemia cells
    Journal Article

    Nason-Burchenal, K.; Takle, G.; Pace, U.; Flynn, S.; Allopenna, J.; Martin, P.; George, S. T.; Goldberg, A. R.; Dmitrovsky, E.
    Oncogene (1998)

    Fulltext@MSK | Save
  • Targeting of PML/RARα is lethal to retinoic acid-resistant promyelocytic leukemia cells
    Journal Article

    Nason-Burchenal, K.; Allopenna, J.; Bègue, A.; Stéhelin, D.; Dmitrovsky, E.; Martin, P.
    Blood (1998)

    Fulltext@MSK | Save
  • Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization
    Journal Article

    Nason-Burchenal, K.; Maerz, W.; Albanell, J.; Allopenna, J.; Martin, P.; Moore, M. A. S.; Dmitrovsky, E.
    Differentiation (1997)

    Fulltext@MSK | Save
  • Introduction of ribozymes cleaving PML/RARα in vitro is growth inhibitory to cultured acute promyelocytic cells
    Meeting Abstract

    Nason-Burchenal, K.; Pace, U.; Takle, G.; Flynn, S.; Allopenna, J.; Martin, P.; George, S. T.; Goldberg, A. R.; Dmitrovsky, E.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Transgenic expression of PML/RARα impairs myelopoiesis
    Journal Article

    Early, E.; Moore, M. A. S.; Kakizuka, A.; Nason-Burchenal, K.; Martin, P.; Evans, R. M.; Dmitrovsky, E.
    Proceedings of the National Academy of Sciences of the United States of America (1996)

    Fulltext@MSK | Save
  • Gene targeting of PML/RAR-alpha reverses retinoid resistance in acute promyelocytic leukemia cells
    Meeting Abstract

    Nason-Burchenal, K.; Martin, P.; Allopenna, J.; Begue, A.; Dmitrovsky, E.
    Proceedings of the American Association for Cancer Research Annual Meeting (1995)

    Fulltext@MSK | Save
  • Over-expression of ribozymes cleaving PML/RAR alpha in vitro is cytotoxic to acute promyelocytic leukemia cells in vivo
    Meeting Abstract

    Nason-Burchenal, K.; Pace, U.; Takle, G.; Flynn, S.; Allopenna, J.; Martin, P.; George, S. T.; Goldberg, A. R.; Dmitrovsky, E.
    Blood (1995)

    Fulltext@MSK | Save